Junshi Biotech is a research and development company that focuses on the development of therapeutic antibodies
Junshi Biotech is a research and development company that focuses on the development of therapeutic antibodies. It has a wide range of technologies, including molecular antibody screening, construction of high-yield stable CHO cell lines and therapeutic antibody analysis and detection. As of the date of this prospectus, a total of 6 drugs have been formally established and are in the research and development stage, and the two drugs which are currently in rapid progress are recombinant humanized anti-PD-1 monoclonal antibody injection (JS001) and recombinant humanized anti-PCSK9 monoclonal antibody injection (JS002).
WIM Presents Next 50 in Global Tech: Healthcare
In 2020, as COVID-19 spread around the world, people began to pay more attention to the healthcare industry. The crisis of the pandemic has led directly to significant changes in the healthcare industry across the globe.
Oct 29, 2020 11:00 AM
Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020
In the times of crisis like COVID-19, even established companies risk falling due to the sudden drop in their income. By contrast, companies that cling to innovation may unlock more value as they fight against the challenges.
Oct 20, 2020 07:40 PM
After China's BNR and GTH Hit Nasdaq, Pan-Cancer Detector GRAIL Eyes IPO
The early-stage cancer-detection technology has declared its mission: to take on and defeat the fatal illness, for the benefit of humanity. Following Burning Rock and Genetron Health, the US biotech GRAIL looks to go public on Nasdaq.
Sep 10, 2020 11:48 AM
Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role.
Sep 09, 2020 03:08 PM
More Room for the Medical Device Market to Grow in China
The medical device market in China is substantial – it also has massive niche markets. The domestic market size growth has surpassed that of the global market for many years, showing strong potential for development.
Aug 29, 2020 08:24 AM